Table 1.
Patients' characteristics.
| Characteristics | Total |
|---|---|
| Patients (n) | 79 |
| Age (year) (x ± s) | 63.62 ± 7.52 |
| Sex (n) (%) | |
| Male | 70 (88.61) |
| Female | 9 (11.39) |
| Smoking history (n) (%) | |
| Yes | 43 (54.43) |
| No | 36 (45.57) |
| BMI (x ± s) | 25.63 ± 4.00 |
| Maximum tumor diameter (cm) (x ± s) | 3.80 ± 2.17 |
| Grade (n) (%) | |
| Low grade | 4 (5.06) |
| High grade | 75 (94.94) |
| Tumor staging (n) (%) | |
| Ta | 5 (6.33) |
| T1 | 18 (22.78) |
| T2 | 27 (34.18) |
| T3 | 26 (32.91) |
| T4 | 3 (3.80) |
| N0 | 60 (75.95) |
| N1 | 12 (15.19) |
| N2 | 7 (8.86) |
| M0 | 75 (94.94) |
| M1 | 4 (5.06) |
| Leukocyte count (×109/L) (x ± s) | 6.54 ± 1.92 |
| Neutrophil count (×109/L) (x ± s) | 4.40 ± 1.72 |
| Lymphocyte count (×109/L) (x ± s) | 1.56 ± 0.60 |
| Platelet count (×109/L) (x ± s) | 232.95 ± 70.52 |
| Monocyte count (×109/L) (x ± s) | 0.41 ± 0.15 |
| NLR (x ± s) | 3.22 ± 2.08 |
| dNLR (x ± s) | 2.22 ± 1.11 |
| PLR (x ± s) | 168.97 ± 80.33 |
| LMR (x ± s) | 4.05 ± 1.50 |
| SII (x ± s) | 740.38 ± 488.08 |
NLR: neutrophil to lymphocyte ratio; dNLR: derived neutrophil to lymphocyte ratio; PLR: platelet to lymphocyte ratio; LMR: lymphocyte to monocyte ratio; SII: systemic immune-inflammation index; BMI: body mass index.